Yangling Kesen Biopharmaceutical

Yangling Kesen Biopharmaceutical is a specialized biotechnology company based in the Yangling Agricultural High-tech Industries Demonstration Zone in Shaanxi, China. The company focuses on the research, development, and industrial-scale production of natural plant extracts and their derivatives for pharmaceutical and agricultural use. Its flagship pharmaceutical product is Galantamine Hydrobromide, a high-purity alkaloid extracted from Lycoris radiata used globally to treat Alzheimer's disease. Beyond human health, the company is a significant producer of botanical pesticides and bio-fertilizers, leveraging its expertise in phytochemical extraction. Yangling Kesen operates GMP-certified manufacturing facilities and maintains a strong presence in both domestic and international ingredient supply chains.